April 1, 2021 (2021-04-01) (Thursday)
Armed conflicts and attacks
Arts and culture
Business and economy
Health and environment
- COVID-19 pandemic
- COVID-19 pandemic in Asia
- COVID-19 pandemic in Bangladesh
- Bangladesh reports a record 6,469 new confirmed cases in the past 24 hours, prompting the government to impose a series of new measures, including banning all travellers from the European Union and 12 other countries for two weeks beginning April 3. (Al Jazeera)
- COVID-19 pandemic in Cambodia
- Phnom Penh imposes a curfew from 8:00 p.m. to 5:00 p.m. local time that suspends all non-essential business activities and gatherings for two weeks in order to prevent the spread of COVID-19. (Khmer Times)
- COVID-19 pandemic in Japan
- The Japanese government designates Osaka, Hyogo, and Miyagi Prefectures for tougher measures against COVID-19 amid a rise in cases. The measures include fines of ¥200,000 ($1,808.80) for restaurants and bars that ignore mandates to shorten operating hours to 8:00 p.m., and capping attendance of large events to 5,000 people. These measures will be effective for one month beginning on April 5. (Kyodo News)
- COVID-19 pandemic in Malaysia, 501.V2 variant
- COVID-19 pandemic in Vietnam
- COVID-19 pandemic in Europe
- COVID-19 pandemic in the United States
- COVID-19 pandemic in Australia
- COVID-19 pandemic in Chile
- After surpassing one million cases, the government announces several new restrictions. Borders will be closed for 30 days; the curfew will start one hour earlier; work permits during quarantine will be given only for essential activities; and sales will be permitted only for food, medicine, and hygiene products. (CNA)
- COVID-19 pandemic in South Africa
- COVID-19 vaccine
- Pfizer–BioNTech COVID-19 vaccine
- Pfizer announces a revised efficacy rating of 91.3% for its vaccine candidate, down from its original rating of 95%, and affirms that protection afforded by the vaccine lasts for at least six months. Pfizer also announces that the vaccine appeared to provide protection against the 501.V2 variant in 100% of cases during its South African trial run. (CNBC)
International relations
Law and crime
Politics and elections